QCM
RYTM icon

Quantinno Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Quantinno Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Buy
3,851
+20
+0.5% +$1.95K ﹤0.01% 2976
2025
Q4 		$410K Buy
3,831
+1,273
+50% +$135K ﹤0.01% 2618
2025
Q3 		$258K Buy
+2,558
New +$237K ﹤0.01% 2574
2025
Q2 		– Sell
-17,086
Closed -$905K – 2623
2025
Q1 		$905K Buy
17,086
+966
+6% +$53.6K 0.01% 1184
2024
Q4 		$902K Hold
16,120
– – 0.01% 1077
2024
Q3 		$845K Sell
16,120
-2,000
-11% -$95.8K 0.01% 989
2024
Q2 		$744K Buy
+18,120
New +$723K 0.01% 911

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Quantinno Capital Management's RYTM Position: Q1 2026 in Review

Quantinno Capital Management increased its Rhythm Pharmaceuticals (RYTM) stake by 0.52% in Q1 2026, buying an estimated $1.95K and bringing the position to 3,851 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #2976.

Quantinno Capital Management first reported a position in RYTM in Q2 2024 and has held it in 7 quarters since. The position peaked at $905K in Q1 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Quantinno Capital Management held 3,851 shares of Rhythm Pharmaceuticals worth $335K as of Q1 2026.
  • Quantinno Capital Management bought 20 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $1.95K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #2976 holding.
  • Quantinno Capital Management first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • Quantinno Capital Management's Rhythm Pharmaceuticals position peaked at $905K in Q1 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.